FDA Seeks More Authority Over DTC Ads Amid Compounding Crackdown
FDA is seeking more authority from Congress to crack down on direct-to-consumer advertising of drugs including compounded products -- a move signaling the agency believes it needs stronger legal grounding after recently warning a slew of telehealth companies not to compare compounded drugs to FDA-approved formulations and targeting Superbowl ads.